Can Researchers Pay People to Participate in Research?

Is It Ethical to Pay People for Research Participation?

Recruiting participants takes time, and participation itself may cost people time, money, effort, or convenience. A natural question follows: can you simply pay people to take part in your study?

In many kinds of human-participant research, the answer is yes. Payment is not inherently unethical, and paying someone does not automatically invalidate voluntary consent. The ethical issues arise from what the payment is for, how it is offered, how much is offered, when it is paid, and whether the arrangement could improperly affect a person's decision about participation.

This distinction matters because researchers sometimes respond to ethical uncertainty by assuming that paying participants should be avoided altogether. That can create its own problems. Participants may incur expenses or give substantial amounts of time to a study, and expecting them to absorb those costs simply because the activity is research is not necessarily the more ethical arrangement.

Yes, Researchers Can Usually Pay Research Participants

Why Paying Research Participants Can Be Ethically Acceptable

Payment Is Not the Same as Buying Consent

A participant who receives money is not selling the researcher permission to ignore research ethics. The researcher still needs an ethically acceptable study, an appropriate consent process, suitable protections for participants, and any required ethics approval.

Payment changes one feature of the participation arrangement: the participant receives something of value in connection with taking part. It does not remove the participant's rights or transform consent into a commercial waiver.

This is reflected in major research-ethics guidance. The U.S. Office for Human Research Protections describes paying research participants as a common and generally acceptable practice. The U.S. Food and Drug Administration takes the same general position for research under its jurisdiction. CIOMS guidance for health-related research also states that participants should reasonably be reimbursed for direct costs and reasonably compensated for their time and inconvenience.

There Are Different Reasons Researchers May Give Participants Money

Not every payment serves the same purpose. A researcher might cover transportation costs, compensate someone for several hours spent completing study procedures, provide a modest token of appreciation, or offer an additional incentive intended to make participation more attractive.

Those distinctions matter ethically because the purpose of the payment affects how it should be evaluated. A reimbursement for a train ticket, for example, raises a different question from a substantial bonus offered only if someone completes every study visit.

The terminology is not perfectly standardized across every institution and jurisdiction, so researchers should check the terminology used by their own ethics committee. The important point is to identify the actual purpose of the payment rather than treating every transfer of money as the same thing. The distinctions among payment, compensation, reimbursement, and incentives become particularly useful when designing the protocol and consent materials.

Paying Someone Can Influence Their Decision Without Making It Unethical

Researchers sometimes become concerned as soon as a participant says, "I wouldn't do the study without the payment." That statement does not by itself establish an ethical problem.

People routinely consider costs and benefits when deciding how to spend their time. A participant may decide that a two-hour interview is not worth the inconvenience without compensation. Payment has influenced the decision, but influence alone is not the same as undue influence.

The more important concern is whether an offer is inappropriate in the circumstances or interferes with a prospective participant's ability to adequately consider the study. OHRP guidance emphasizes that the effect of an offer depends on context, including the study population and circumstances in which the offer is made. The Belmont Report similarly distinguishes ordinary influence from undue influence and connects valid consent with voluntariness.

Researchers therefore should not treat undue influence as another name for any motivation created by payment. The ethical analysis is more demanding than asking whether money affected the decision at all.

Payment Is Also Different From Coercion

Coercion and payment are often discussed together, but they are not synonymous. In research ethics, coercion ordinarily involves a threat of harm, penalty, or loss used to obtain compliance. A genuine offer of money ordinarily does not contain such a threat.

This is why the size of a payment should not automatically be treated as evidence that a participant has been coerced. A large offer may warrant careful examination for other reasons, including possible undue influence, but large payment and coercion are conceptually different issues.

Payment Does Not Make an Otherwise Unacceptable Study Acceptable

Suppose a study exposes participants to risks that an ethics committee considers unjustifiable. Increasing the payment does not repair the underlying problem. Payment is not a license to impose unacceptable research procedures.

FDA guidance specifically does not treat payment for participation as a research benefit to be placed on the benefit side of a risk-benefit assessment. This distinction prevents a problematic logic in which enough money could supposedly compensate for an otherwise unacceptable research design.

The Payment Plan Is Part of the Ethical Review

When a study requires ethics review, payment should not be improvised after approval or treated as an administrative detail outside the protocol. The ethics committee or IRB may need to evaluate the purpose, amount, method, timing, conditions, and disclosure of payment.

FDA guidance, for example, states that the amount and schedule of payments should be presented to the IRB during initial review and that payment information should be included in the informed consent document. OHRP similarly advises that proposed levels and purposes of remuneration should be justified and clearly described in consent materials.

Requirements vary by jurisdiction, institution, funder, and type of research. Researchers should therefore follow the rules governing their particular study rather than assuming that one institution's payment policy applies everywhere.

There Is No Universal Ethical Price for Participation

Once researchers establish that payment is permissible, a harder question appears: how much?

There is no single amount that is ethically correct across all studies. A brief online questionnaire, a two-hour laboratory session, a longitudinal interview study, and a clinical trial involving repeated site visits impose very different demands. Local economic conditions also matter.

The amount should therefore have a defensible rationale. Depending on the study and applicable guidance, researchers may consider time, expenses, effort, inconvenience, and the function the payment is intended to serve. The more specific question of when participant payment becomes too much requires its own contextual analysis rather than a universal monetary threshold.

Participants Should Know the Payment Terms Before They Consent

A prospective participant should not have to discover important payment conditions after joining the study. Relevant consent information should explain the amount or form of payment, when it will be provided, what portions accrue during participation, and what happens if participation ends early when those conditions apply.

This is particularly important in multi-visit or longitudinal studies. A payment structure that effectively requires participants to finish the entire study before receiving money they have already earned may discourage withdrawal. FDA guidance generally expects payment credit to accrue as participation progresses rather than making the entire payment contingent on study completion.

The detailed ethical questions surrounding payment after withdrawal and prorating payment according to completed participation should therefore be settled before recruitment begins, not after the first participant withdraws.

What Ethical Participant Payment Might Look Like in Practice

The presence of payment does not make this hypothetical study unethical. Nor does the fact that some people might participate only because payment is available. The ethical analysis instead examines whether the study itself is acceptable, the payment has a defensible purpose, the terms are fair and transparent, and consent remains voluntary.

Common Misunderstandings About Paying Research Participants

How to Decide Whether and How to Pay Participants

If you are designing a study, begin with the purpose of the payment rather than choosing an amount first. Ask what participants will contribute or incur and what the proposed payment is intended to address.

Do not choose an amount merely because another researcher used it. A payment that made sense for a ten-minute online study in one location may be inappropriate for a three-hour laboratory procedure somewhere else. Your rationale should correspond to your study, population, local context, and applicable ethics requirements.

It is also useful to decide explicitly what the participant payment is supposed to compensate for. That question often clarifies several later decisions about amount, timing, reimbursement, and withdrawal.

Before Offering Payment to Research Participants

Frequently Asked Questions About Paying Research Participants

Paying Research Participants Can Be Ethical

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.